Share
 
Title
Next Generation PrEP: From Science to Community Impact
Code
SA039
Session Type
Satellite
Format
Hybrid
ROOM/CHANNEL
Room 517b/Channel 4
Date Time
29 July 18:15 - 19:45
Organizer
The Forum for Collaborative Research

Engaging multiple stakeholders across industry, regulatory agencies, patient groups, and academic research to discuss important considerations for trials in next-generation PrEP products. How do clinical trials best assess efficacy for PrEP when standards of care are highly efficacious? How do regulators approach groundbreaking new trial designs in HIV prevention? How do these trial designs affect patients in the trials and those that may benefit from candidate drugs?

18:15
5 min
 Introductory Remarks
Veronica MILLER, Forum for Collaborative Research, United States
18:20
5 min
 Introduction from Co-Chairs
Helen REES, Wits Reproductive Health and HIV Institute, South Africa
Kenneth MAYER, Fenway Health, United States
18:25
15 min
 SCIENCE: Reflections on Use of Counterfactual Placebo in HIV Prevention Trial Design
Deborah DONNELL, Fred Hutch Cancer Research Center, United States
18:40
10 min
 SCIENCE: Use of the Recent Infection Testing Algorithm to Estimate Background HIV Incidence in Micro-Epidemic Areas Within Uganda
Flavia Kiweewa MATOVU, MU-JHU Research Collaboration, Uganda
18:50
10 min
 SCIENCE: Using Recent Infection Testing Algorithms in Background HIV Incidence Estimation
Eduard GREBE, Vitalant Research Institute, South Africa
19:00
5 min
 COMMUNITY IMPACT: Maximizing the Use of Data for Community Impact
Grace KUMWENDA, Pakachere IHDC, Malawi
19:05
30 min
 COMMUNITY IMPACT: Maximizing the Use of Data for Community Impact
Jeremy SUGARMAN, Johns Hopkins University, United States
Joan NABAWANUKA, Makerere University Johns Hopkins Research Collaboration (MUJHU- Care Ltd), Uganda
Ntando YOLA, Desmond Tutu Health Foundation, South Africa
19:35
10 min
 Completing the Circle: A Moderated Q&A
Veronica MILLER, Forum for Collaborative Research, United States
Helen REES, Wits Reproductive Health and HIV Institute, South Africa
Kenneth MAYER, Fenway Health, United States
Flavia Kiweewa MATOVU, MU-JHU Research Collaboration, Uganda
Eduard GREBE, Vitalant Research Institute, South Africa
Deborah DONNELL, Fred Hutch Cancer Research Center, United States
Jeremy SUGARMAN, Johns Hopkins University, United States
Joan NABAWANUKA, Makerere University Johns Hopkins Research Collaboration (MUJHU- Care Ltd), Uganda
Ntando YOLA, Desmond Tutu Health Foundation, South Africa